Pulmonary Rehabilitation in End-Stage Liver Disease

Mayo Clinic4 enrolled

Overview

The purpose of this study is to assess the impact of exercise on sarcopenia and frailty. The exercise that will be performed in this study will include either pulmonary rehabilitation or a formal home based video strengthening program

Participants will be randomized into two groups. The Pulmonary Rehabilitation group will undergo exercise under a supervised setting for a total duration of 12 weeks. Patients will perform endurance (treadmill or cycle ergometer), strength (weight resistance) and flexibility training twice a week for a period of an hour per session. Exercises will be supervised by physiotherapists or exercise physiologists. Compliance and performance will be monitored by the trainer. They will receive a pedometer for home use. The Home based program group will perform REST for 10 minutes daily, increasing to 20 minutes daily, after the second week, in their home environment. The total duration of the intervention will be 12 weeks. Patients will be provided with pedometers, REST video and binder, with instructions on how to perform exercises, and resistance bands.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

End Stage Liver Disease

Interventions

Pulmonary Rehabilitation ExerciseBEHAVIORAL

Participants will undergo Pulmonary Rehabilitation exercise. Participants will perform endurance (treadmill or cycle ergometer), strength (weight resistance) and flexibility training twice a week for a period of an hour per session

Home Based ExerciseBEHAVIORAL

Participants will undergo Home based exercise program consisting of strength and conditioning. Participants will perform REST for 10 minutes daily, increasing to 20 minutes daily, after the second week, in their home environment. The total duration of the intervention will be 12 weeks. Participants will be provided with pedometers, REST video and binder, with instructions on how to perform exercises, and resistance bands.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * wait listed for liver transplantation with poor 6 MWT Exclusion Criteria: * age \< 18 years * recent hospitalization (within 14 days) due to decompensation, variceal bleeding in the previous 1 month * large esophageal varices without primary prophylaxis * active excessive alcohol intake (in the previous 3 months) * current overt uncontrolled hepatic encephalopathy * hepatopulmonary syndrome with uncontrolled hypoxia * portopulmonary hypertension * inability to perform exercise * marked symptomatic comorbidities (cardiac, pulmonary, renal).

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Outcomes

Primary Outcomes

Change in 6 minute walk test

Participants will walk on a straight, flat surface for 6 minutes at a self-determined pace.

Time frame: baseline, 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.